Microcephaly
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis.
|
27737959 |
2016 |
Microcephaly
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
|
31523845 |
2019 |
Liver carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis.
|
27737959 |
2016 |
Moderate intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sloping forehead
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital chromosomal disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Furthermore, NCAPH-knockdown cells showed an increase in chromosomal aberrations and DNA damage via activation of the DNA damage response (Chk1/Chk2) signaling pathways.
|
31784646 |
2019 |
Pancreatic carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our results showed that NCAPH was overexpressed in clinical PC specimens (GEPIA) and cell lines.
|
31784646 |
2019 |
Malignant neoplasm of pancreas
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our results showed that NCAPH was overexpressed in clinical PC specimens (GEPIA) and cell lines.
|
31784646 |
2019 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analysis revealed that NCAPH is involved in regulating the PCa cell cycle by interacting with a number of proteins, including non-SMC condensin I complex subunit D2, non-SMC condensin I complex subunit G, structural maintenance of chromosomes 4, structural maintenance of chromosomes 2, Aurora kinase A, Aurora kinase B, cyclin-dependent kinase 1, H2A histone family member Z, POC1 centriolar protein A and histone cluster 2 H2A family member C. In summary, the present results suggest NCAPH may be a novel and beneficial diagnostic and therapeutic target in PCa.
|
31186803 |
2019 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analysis revealed that NCAPH is involved in regulating the PCa cell cycle by interacting with a number of proteins, including non-SMC condensin I complex subunit D2, non-SMC condensin I complex subunit G, structural maintenance of chromosomes 4, structural maintenance of chromosomes 2, Aurora kinase A, Aurora kinase B, cyclin-dependent kinase 1, H2A histone family member Z, POC1 centriolar protein A and histone cluster 2 H2A family member C. In summary, the present results suggest NCAPH may be a novel and beneficial diagnostic and therapeutic target in PCa.
|
31186803 |
2019 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
|
31523845 |
2019 |
Metastatic castration-resistant prostate cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p.
|
30818424 |
2019 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, these findings reveal an important role of NCAPH in CC, indicating that NCAPH could be used as a new therapeutic target in future.
|
28300828 |
2017 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Collectively, these findings reveal an important role of NCAPH in CC, indicating that NCAPH could be used as a new therapeutic target in future.
|
28300828 |
2017 |